NK cells are never alone: crosstalk and communication in tumour microenvironments

Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cell...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer Vol. 22; no. 1; pp. 34 - 24
Main Authors Zhou, Yongqiang, Cheng, Lu, Liu, Lu, Li, Xun
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 16.02.2023
BioMed Central
BMC
Subjects
Adenosine
Antigens
Apoptosis
Cancer
Cancer therapies
Care and treatment
Cell interactions
Communication
Crosstalk
Cytokines
Cytotoxicity
Humans
Hypoxia
Immunotherapy
Killer cells
Killer Cells, Natural
Ligands
Metastases
Microenvironments
Natural killer cells
Neoplasms - metabolism
NK cells
Proteins
Review
Stem cells
TME
Tumor Microenvironment
Tumors
NK cells
TME
Crosstalk
Cancer
Communication
Online AccessGet full text

Cover

Abstract Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future.
AbstractList Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future.
Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future.Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future.
Abstract Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future.
Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future. Keywords: NK cells, Crosstalk, Communication, Cancer, TME
ArticleNumber 34
Audience Academic
Author Li, Xun
Zhou, Yongqiang
Cheng, Lu
Liu, Lu
Author_xml – sequence: 1
  givenname: Yongqiang
  surname: Zhou
  fullname: Zhou, Yongqiang
– sequence: 2
  givenname: Lu
  surname: Cheng
  fullname: Cheng, Lu
– sequence: 3
  givenname: Lu
  surname: Liu
  fullname: Liu, Lu
– sequence: 4
  givenname: Xun
  surname: Li
  fullname: Li, Xun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36797782$$D View this record in MEDLINE/PubMed
BookMark eNp9kltrFTEQxxep2It-AR9kwZe-bM1lNxcfhFK8FIsi6HOYTbLHHHeTmuwW_PbOOafWniISQkLym38yM__j6iCm6KvqOSVnlCrxqlCmW94QhpNKLhv5qDqirRRN22l1cG9_WB2XsiZIKdk-qQ65kFpKxY6qL58-1taPY6kh-zr6G59rGPGd17XNqZQZxh81RFfbNE1LDBbmkGIdYj0vU1pyPQXkfLwJOcXJx7k8rR4PMBb_7HY9qb69e_v14kNz9fn95cX5VWM7wefGKjKwXvVAuXaWUYp71oPwzilFFCXUOs477XUHhLV9JwCY76WjviedA35SXe50XYK1uc5hgvzLJAhme5DyykCegx290YBynDLWedI6Cwo6SnTrhGV9T9iAWm92WtdLP3lnMY8M457o_k0M380q3RitOedaocDprUBOPxdfZjOFsqkrRJ-WYhhWWxAqRIfoywfoGusYsVQbCrmOSPGXWgEmEOKQ8F27ETXn2GpB2x119g8Kh_PYF-ziEPB8L-DF_UTvMvxjCATYDth2P_vhDqHEbFxndq4z6DqzdZ2RGKQeBNkwb42C3wnj_0J_A3qW2uc
CitedBy_id crossref_primary_10_1158_2326_6066_CIR_23_1061
crossref_primary_10_1016_j_nantod_2024_102286
crossref_primary_10_37349_etat_2024_00227
crossref_primary_10_1016_j_phrs_2024_107241
crossref_primary_10_1016_j_jconrel_2024_08_047
crossref_primary_10_1002_cam4_7315
crossref_primary_10_3389_fimmu_2024_1420205
crossref_primary_10_3390_genes15091165
crossref_primary_10_1016_j_jddst_2023_105248
crossref_primary_10_3390_cells12121606
crossref_primary_10_1016_j_nantod_2023_102075
crossref_primary_10_1002_mco2_387
crossref_primary_10_3390_cells13181567
crossref_primary_10_1007_s10555_025_10242_w
crossref_primary_10_3390_ijms252413722
crossref_primary_10_3389_fimmu_2023_1260859
crossref_primary_10_3389_fonc_2024_1428018
crossref_primary_10_3389_fimmu_2024_1474652
crossref_primary_10_1016_j_ymthe_2024_06_034
crossref_primary_10_1016_j_prp_2024_155166
crossref_primary_10_2147_CMAR_S502155
crossref_primary_10_1186_s12957_024_03490_7
crossref_primary_10_3389_fcell_2025_1532491
crossref_primary_10_3390_molecules28155804
crossref_primary_10_1111_jcmm_18549
crossref_primary_10_3389_fimmu_2025_1518555
crossref_primary_10_1186_s40364_025_00727_9
crossref_primary_10_1186_s12943_024_02210_9
crossref_primary_10_1038_s43018_023_00636_6
crossref_primary_10_3389_fcell_2023_1261749
crossref_primary_10_1016_j_beem_2024_101931
crossref_primary_10_1038_s41392_024_01769_5
crossref_primary_10_3389_fcimb_2025_1511900
crossref_primary_10_1016_j_bbcan_2025_189281
crossref_primary_10_1186_s12943_023_01826_7
crossref_primary_10_3389_fimmu_2023_1227064
crossref_primary_10_1016_j_intimp_2024_113037
crossref_primary_10_3389_fimmu_2024_1366096
crossref_primary_10_3389_fimmu_2024_1341390
crossref_primary_10_3390_cells13191666
crossref_primary_10_3390_cancers16061113
crossref_primary_10_1038_s41598_025_88071_8
crossref_primary_10_1080_19490976_2024_2302065
crossref_primary_10_15616_BSL_2023_29_4_371
crossref_primary_10_1038_s41413_024_00359_z
crossref_primary_10_1186_s13045_024_01634_6
crossref_primary_10_3389_fimmu_2024_1478922
crossref_primary_10_3390_nu16234143
crossref_primary_10_1007_s12282_024_01654_7
crossref_primary_10_1186_s12935_023_03064_9
crossref_primary_10_1007_s11684_024_1090_6
crossref_primary_10_3389_fimmu_2024_1492323
crossref_primary_10_4110_in_2024_24_e34
crossref_primary_10_3390_ijms25105151
crossref_primary_10_3389_fimmu_2024_1440764
crossref_primary_10_1007_s12032_025_02647_y
crossref_primary_10_1038_s41597_024_03721_2
crossref_primary_10_3390_cancers15123222
crossref_primary_10_1002_advs_202310204
crossref_primary_10_1007_s10495_024_02039_z
crossref_primary_10_2174_1568009623666230712095021
Cites_doi 10.1073/pnas.2015343117
10.1084/jem.20051511
10.4049/jimmunol.1301297
10.3390/cancers13030473
10.1182/blood.V92.11.4248
10.1016/j.cell.2021.09.019
10.1136/jitc-2020-001054
10.1096/fj.08-105866
10.3390/ijms221910227
10.1126/scisignal.aad1884
10.3390/vaccines9121488
10.1016/j.immuni.2015.01.010
10.1038/s41580-022-00460-3
10.1371/journal.pone.0191358
10.1056/NEJM198612253152606
10.1016/j.jcyt.2022.07.012
10.1158/0008-5472.CAN-18-0779
10.1007/s10059-011-1057-8
10.1016/j.it.2019.09.002
10.1016/j.bbrc.2017.05.034
10.4049/jimmunol.1000106
10.1016/j.canlet.2011.12.020
10.1016/j.celrep.2021.109210
10.1038/s41467-017-01599-w
10.1073/pnas.0730640100
10.3389/fimmu.2019.01414
10.1158/0008-5472.CAN-14-2788
10.1182/blood-2010-06-287243
10.1093/jnci/dju200
10.1002/sctm.18-0123
10.1038/nrclinonc.2016.217
10.4049/jimmunol.1201542
10.3389/fimmu.2021.643310
10.1126/sciadv.aba8564
10.3390/cancers13102397
10.4049/jimmunol.1500447
10.1371/journal.pone.0047664
10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G
10.1186/s12943-021-01428-1
10.1016/j.jaci.2018.06.047
10.1016/j.cyto.2013.11.010
10.4161/21624011.2014.952197
10.1038/nature16140
10.1186/s12977-015-0191-3
10.1053/j.seminhematol.2020.10.003
10.1016/j.tranon.2019.10.001
10.1038/s41590-019-0511-1
10.1158/1078-0432.CCR-12-2426
10.1016/j.immuni.2021.03.024
10.1111/cas.14537
10.1038/7403
10.1016/j.ceb.2021.04.007
10.1074/jbc.M115.651547
10.1136/jitc-2021-003237
10.3892/ijo.2016.3631
10.1016/j.jhep.2022.03.011
10.1073/pnas.1909110117
10.3390/ijms22084091
10.1074/jbc.M112.340588
10.1158/2159-8290.CD-20-1808
10.1016/j.immuni.2020.05.001
10.1172/JCI157340
10.1182/blood-2013-10-533398
10.1084/jem.20092749
10.3389/fimmu.2020.621225
10.1002/stem.1563
10.4049/jimmunol.173.6.3716
10.1016/j.cell.2011.02.013
10.3389/fimmu.2018.02358
10.18632/aging.203914
10.1189/jlb.3AB0316-140RR
10.4049/jimmunol.178.8.4947
10.3389/fimmu.2020.00297
10.1007/s13402-020-00523-7
10.3389/fcell.2022.808859
10.1158/0008-5472.CAN-13-0992
10.1155/2014/143463
10.4049/jimmunol.1203401
10.1038/s41576-020-00300-0
10.4049/jimmunol.163.10.5211
10.1158/2326-6066.CIR-20-1023
10.1016/j.cell.2021.04.016
10.1016/j.omto.2021.06.005
10.1016/j.biomaterials.2012.04.041
10.1056/NEJMoa1910607
10.4049/jimmunol.0803523
10.1038/s41568-021-00366-w
10.3389/fimmu.2021.688918
10.1172/JCI129338
10.3389/fimmu.2017.00868
10.1016/j.immuni.2016.03.012
10.1038/cddis.2015.327
10.1634/stemcells.2004-0359
10.1038/s41556-018-0138-8
10.1084/jem.20190354
10.1083/jcb.202001134
10.1002/(SICI)1097-0215(19990315)80:6<880::AID-IJC14>3.0.CO;2-Y
10.3390/cells12010121
10.1016/j.molmed.2021.12.008
10.1038/s41392-021-00641-0
10.1007/s00262-012-1200-1
10.4049/jimmunol.179.10.6651
10.1158/2159-8290.CD-21-0010
10.1158/2326-6066.CIR-17-0604
10.1016/j.semcancer.2019.06.003
10.1016/j.biomaterials.2022.121730
10.1007/s40291-021-00550-6
10.4049/jimmunol.1202702
10.1038/s41586-022-04772-4
10.1080/20013078.2017.1294368
10.1016/j.cell.2020.12.016
10.1038/s41592-021-01203-6
10.1016/j.clim.2004.04.003
10.1016/j.cell.2020.07.019
10.1038/nmat3355
10.21037/atm-21-347
10.1093/intimm/dxq434
10.1038/s41392-020-00280-x
10.3390/cancers11101560
10.3389/fimmu.2017.00248
10.3390/cancers13092184
10.1016/j.jaut.2020.102417
10.3389/fimmu.2020.00167
10.1158/1078-0432.CCR-15-2710
10.1021/acsnano.9b10103
10.1182/blood-2008-02-135871
10.1007/s00262-018-2204-2
10.1186/s13287-022-02777-4
10.1016/j.cmet.2016.08.011
10.1074/jbc.M116.737130
10.1158/1078-0432.CCR-13-0505
10.1016/j.cellimm.2015.11.009
10.4049/jimmunol.176.3.1582
10.1111/cas.14418
10.1038/s42255-020-0243-4
10.1136/jitc-2022-005769
10.1146/annurev-immunol-020711-075005
10.1182/blood-2004-09-3775
10.1016/j.celrep.2015.11.053
10.1038/s41375-021-01478-w
10.1016/j.it.2017.12.001
10.1038/s41577-019-0210-z
10.1073/pnas.2200568119
10.1016/j.intimp.2021.108374
10.1186/s12943-020-01238-x
10.1016/j.cell.2020.03.034
10.1016/j.cell.2018.11.021
10.1172/JCI67484
10.1038/nm.3394
10.1016/j.bbmt.2010.10.019
10.7150/thno.18752
10.1002/cac2.12294
10.1158/2326-6066.CIR-18-0481
10.1158/2326-6066.CIR-17-0273
10.1158/2326-6066.CIR-17-0498
10.4049/jimmunol.1700737
10.1016/j.ymthe.2017.06.012
10.1242/jcs.258570
10.1016/j.cell.2016.02.025
10.1016/j.molmed.2018.10.005
10.1111/j.1365-2141.2005.05842.x
10.1016/j.canlet.2015.07.009
10.1136/jitc-2021-003894
10.1016/j.actbio.2019.02.014
10.1038/s41419-019-1435-2
10.1371/journal.pone.0009874
10.1038/nrd.2018.169
10.1158/1078-0432.CCR-19-1090
10.1002/mc.21863
10.1016/j.cell.2018.10.014
10.1038/s41388-017-0106-y
10.1038/s41571-020-0426-7
10.1016/j.pharmthera.2020.107753
10.1016/j.reth.2021.02.006
10.4049/jimmunol.0802845
10.1186/s12943-021-01492-7
10.1182/blood-2004-06-2272
10.1182/blood-2002-09-2876
10.1038/srep39833
10.1016/j.ccell.2016.09.011
10.15252/embj.201696264
10.1016/j.immuni.2016.07.005
10.1038/s41577-019-0127-6
10.1080/2162402X.2017.1393598
10.1038/ncomms7623
10.1038/s41590-020-0728-z
10.3389/fimmu.2019.00009
10.3389/pore.2021.1609802
10.1126/sciadv.abj3286
10.1016/S1074-7613(03)00264-4
10.1182/blood-2010-12-325324
10.1073/pnas.0530291100
10.1073/pnas.2101169118
10.1158/0008-5472.CAN-14-3041
10.1073/pnas.0910074107
10.1002/jcp.30038
10.1016/j.cell.2015.08.016
10.3390/cancers13153865
10.3389/fimmu.2020.586126
10.1016/j.canlet.2020.09.021
10.3892/mmr.2017.6921
10.3727/096368910X564076
10.1158/2326-6066.CIR-17-0204
10.1038/ni.3800
10.1136/jitc-2022-004725
10.3389/fcell.2021.609532
10.1016/j.tranon.2020.100825
10.1126/science.1092385
10.3389/fimmu.2017.00699
10.1016/j.smim.2020.101409
10.1038/s41467-020-18125-0
10.3390/cancers12030661
10.1186/s12943-021-01486-5
10.1158/0008-5472.CAN-13-2563
10.4049/jimmunol.181.6.3784
10.1038/s41375-020-01065-5
10.1182/blood-2010-08-300954
10.1182/blood-2005-07-2775
10.1089/scd.2019.0059
10.1182/blood-2014-03-453217
10.1371/journal.pone.0010088
10.2217/imt.11.102
10.3389/fimmu.2022.816761
10.1186/s13046-021-02128-w
10.1002/eji.201343448
10.1158/2159-8290.CD-15-1157
10.3389/fimmu.2021.695859
10.3389/fimmu.2021.733317
10.3389/fimmu.2018.01150
10.1172/JCI132712
10.3390/cancers14112608
10.1038/s41591-018-0085-8
10.1016/j.semcancer.2018.08.001
10.3390/cancers12123871
10.1186/s12935-021-02400-1
10.15252/emmm.202114073
10.1080/19420862.2021.1950264
10.1073/pnas.1411072112
10.1038/s43018-020-0068-9
10.1016/j.immuni.2021.11.003
10.1038/s41586-021-03614-z
10.1084/jem.20112738
10.1016/S1470-2045(04)01597-9
10.1038/s41568-020-0272-z
10.1158/1078-0432.CCR-21-2767
10.1021/acsami.7b02258
10.1039/C7LC00963A
10.1182/blood-2007-02-074997
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12943-023-01737-7
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic

CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-4598
EndPage 24
ExternalDocumentID oai_doaj_org_article_9a10131225e04dca8a51094d6c2bb02f
PMC9933398
A737614076
36797782
10_1186_s12943_023_01737_7
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: ;
  grantid: 82060119
GroupedDBID ---
0R~
123
29M
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PZZ
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
FRP
NPM
PMFND
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-c80f2b8ba139dc211b8b2ba6edd8808101cd3359e95a024b56aa2eb7d1eb05da3
IEDL.DBID M48
ISSN 1476-4598
IngestDate Wed Aug 27 01:03:42 EDT 2025
Thu Aug 21 18:38:16 EDT 2025
Thu Jul 10 23:53:31 EDT 2025
Fri Jul 25 06:26:10 EDT 2025
Tue Jun 17 21:44:53 EDT 2025
Tue Jun 10 20:28:46 EDT 2025
Thu Jan 02 22:52:12 EST 2025
Tue Jul 01 01:01:21 EDT 2025
Thu Apr 24 23:00:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords NK cells
TME
Crosstalk
Cancer
Communication
Language English
License 2023. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-c80f2b8ba139dc211b8b2ba6edd8808101cd3359e95a024b56aa2eb7d1eb05da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/2777785076?pq-origsite=%requestingapplication%
PMID 36797782
PQID 2777785076
PQPubID 42702
PageCount 24
ParticipantIDs doaj_primary_oai_doaj_org_article_9a10131225e04dca8a51094d6c2bb02f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9933398
proquest_miscellaneous_2778601665
proquest_journals_2777785076
gale_infotracmisc_A737614076
gale_infotracacademiconefile_A737614076
pubmed_primary_36797782
crossref_primary_10_1186_s12943_023_01737_7
crossref_citationtrail_10_1186_s12943_023_01737_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-02-16
PublicationDateYYYYMMDD 2023-02-16
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-16
  day: 16
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Molecular cancer
PublicationTitleAlternate Mol Cancer
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References PA Sotiropoulou (1737_CR140) 2006; 24
M Parodi (1737_CR169) 2018; 9
AE Sköld (1737_CR70) 2018; 67
M Boulch (1737_CR260) 2019; 40
IA Batista (1737_CR28) 2021; 13
J Hao (1737_CR197) 2010; 207
P Li (1737_CR91) 2020; 11
H Zhou (1737_CR200) 2022; 42
R Hosseini (1737_CR29) 2022; 21
C Li (1737_CR110) 2021; 9
B Carter (1737_CR253) 2021; 22
R Mocikat (1737_CR46) 2003; 19
RS Waterman (1737_CR147) 2010; 5
N Aziz (1737_CR205) 2016; 7
Y Xiao (1737_CR1) 2021; 221
H Thomas (1737_CR144) 2014; 2014
MZ Jin (1737_CR5) 2020; 5
M Jin (1737_CR188) 2022; 10
C Liu (1737_CR132) 2020; 14
M Giuliani (1737_CR143) 2011; 118
H Tsuchiya (1737_CR164) 2021; 17
D Hanahan (1737_CR167) 2011; 144
1737_CR80
G van Niel (1737_CR27) 2022; 23
A Mantovani (1737_CR108) 2017; 14
R Tallerico (1737_CR158) 2013; 190
KC Barry (1737_CR75) 2018; 24
J Ni (1737_CR174) 2020; 52
E Krzywinska (1737_CR175) 2017; 8
AL Correia (1737_CR221) 2021; 594
SK Phung (1737_CR228) 2021; 25
Y Zhang (1737_CR104) 2020; 217
Y Jiang (1737_CR36) 2021; 9
I Rousalova (1737_CR22) 2010; 37
1737_CR154
H Salmon (1737_CR74) 2016; 44
R Castriconi (1737_CR157) 2009; 182
JT Neal (1737_CR256) 2018; 175
T Delvaeye (1737_CR20) 2018; 24
A Poli (1737_CR198) 2013; 190
F Wu (1737_CR123) 2021; 6
S Kakiuchi-Kiyota (1737_CR234) 2022; 36
A Schmidt (1737_CR85) 2006; 13
A Tittarelli (1737_CR21) 2014; 192
S Agaugué (1737_CR41) 2008; 112
AG Bozward (1737_CR55) 2021; 12
JW Dean (1737_CR63) 2020; 108
A Shanker (1737_CR51) 2007; 179
S Viel (1737_CR130) 2016; 9
ND Huntington (1737_CR39) 2020; 20
MZ Akhter (1737_CR163) 2018; 37
JA Myers (1737_CR40) 2021; 18
B Abbasi (1737_CR146) 2022; 13
ES Jang (1737_CR245) 2012; 33
K Miyazato (1737_CR249) 2020; 111
S Sheppard (1737_CR179) 2021; 35
SK Wculek (1737_CR67) 2020; 20
T Inoue (1737_CR127) 2016; 49
EE Er (1737_CR219) 2018; 20
T Wu (1737_CR178) 2021; 23
JE Boudreau (1737_CR17) 2016; 45
RM Srivastava (1737_CR52) 2013; 19
E Ames (1737_CR160) 2015; 195
J Park (1737_CR242) 2012; 11
SY Nuñez (1737_CR115) 2018; 200
X Zheng (1737_CR172) 2019; 20
IS Chan (1737_CR213) 2020; 219
W Park (1737_CR244) 2017; 9
AY Jong (1737_CR32) 2017; 6
P Trzonkowski (1737_CR57) 2004; 112
D Friedman (1737_CR201) 2021; 134
L Cassetta (1737_CR107) 2018; 17
T Yin (1737_CR159) 2016; 300
P André (1737_CR239) 2018; 175
X Mao (1737_CR124) 2021; 20
K Ogura (1737_CR92) 2018; 6
T Li (1737_CR126) 2012; 318
R Xiao (1737_CR191) 2021; 12
M Lin (1737_CR240) 2020; 130
AL Di Pace (1737_CR34) 2020; 12
H Dianat-Moghadam (1737_CR214) 2021; 497
MF Kaminski (1737_CR235) 2022; 10
G Sconocchia (1737_CR50) 2014; 3
M Timaner (1737_CR136) 2020; 60
M Bradley (1737_CR14) 1998; 92
1737_CR181
M Tang (1737_CR79) 2015; 13
J Shimizu (1737_CR56) 1999; 163
W Luo (1737_CR227) 2022; 13
1737_CR38
GM Spaggiari (1737_CR139) 2008; 111
A Wiernik (1737_CR231) 2013; 19
AP McFarland (1737_CR250) 2021; 54
1737_CR189
TA Fehniger (1737_CR44) 2003; 101
1737_CR186
HC Lo (1737_CR217) 2020; 1
I Christodoulou (1737_CR222) 2021; 9
J Ma (1737_CR204) 2021; 40
E Littwitz-Salomon (1737_CR62) 2015; 12
JP Bottcher (1737_CR71) 2018; 172
S Wang (1737_CR83) 2022; 77
I Terren (1737_CR170) 2020; 57
T Bald (1737_CR237) 2020; 21
1737_CR190
J Song (1737_CR254) 2021; 12
W Liu (1737_CR59) 2017; 488
S Malladi (1737_CR218) 2016; 165
C Cui (1737_CR90) 2021; 184
MJ Crop (1737_CR150) 2011; 20
A Perez-Martinez (1737_CR81) 2011; 17
NC Fernandez (1737_CR68) 1999; 5
1737_CR196
SK Wculek (1737_CR89) 2015; 528
EO Long (1737_CR15) 2013; 31
JY Park (1737_CR118) 2011; 32
IM Meraz (1737_CR243) 2018; 6
SM Lewis (1737_CR258) 2021; 18
T Doi (1737_CR65) 2019; 25
IB Barsoum (1737_CR168) 2014; 74
P Peng (1737_CR48) 2022; 10
TD Holmes (1737_CR73) 2014; 111
A Balatsoukas (1737_CR194) 2022; 28
Y Gao (1737_CR116) 2017; 18
C Borrelli (1737_CR31) 2018; 6
DG DeNardo (1737_CR109) 2019; 19
Z Husain (1737_CR187) 2013; 191
C Costantini (1737_CR99) 2010; 22
KC Lam (1737_CR207) 2021; 184
BK Pliyev (1737_CR97) 2014; 65
R Castriconi (1737_CR113) 2003; 100
M Khan (1737_CR238) 2020; 11
R Singh (1737_CR84) 2022; 24
HF Wang (1737_CR145) 2012; 20
SM Poznanski (1737_CR176) 2019; 10
1737_CR53
D Fawkner-Corbett (1737_CR252) 2021; 184
D Costa (1737_CR135) 2018; 9
EC Nakajima (1737_CR183) 2013; 52
C-HD Hu (1737_CR148) 2019; 28
I Navin (1737_CR241) 2020; 12
EM Reiche (1737_CR193) 2004; 5
ÂC Crespo (1737_CR25) 2020; 182
A Ben-Shmuel (1737_CR203) 2021; 9
SA Nalawade (1737_CR226) 2021; 9
A Jewett (1737_CR152) 2010; 5
V Cazzetta (1737_CR76) 2021; 13
L Zhu (1737_CR33) 2017; 7
M Gallazzi (1737_CR121) 2020; 11
M Moloudizargari (1737_CR138) 2021; 236
P Scapini (1737_CR93) 2014; 124
Q Fu (1737_CR141) 2017; 16
S Gaggero (1737_CR112) 2020; 11
UY Moreno-Nieves (1737_CR251) 2021; 118
KM Au (1737_CR246) 2020; 6
AI Romero (1737_CR96) 2006; 132
J Zhou (1737_CR111) 2021; 101
LY Ke (1737_CR255) 2017; 18
O Matalon (1737_CR202) 2018; 37
M Klopotowska (1737_CR223) 2022; 10
F Gao (1737_CR137) 2016; 7
A Bruno (1737_CR11) 2014; 106
M Li (1737_CR161) 2012; 61
S Pal (1737_CR208) 2022; 132
R Kanzaki (1737_CR125) 2020; 111
J Massagué (1737_CR211) 2021; 11
M Amand (1737_CR9) 2017; 8
G Biber (1737_CR247) 2022; 14
A Zingoni (1737_CR42) 2004; 173
JC Cancel (1737_CR82) 2019; 10
E Liu (1737_CR7) 2020; 382
K Renner (1737_CR182) 2017; 8
DM Kingsley (1737_CR257) 2019; 95
NK Wolf (1737_CR54) 2022; 119
A Horowitz (1737_CR43) 2010; 184
LH Lv (1737_CR30) 2012; 287
MS Hasim (1737_CR220) 2022; 8
C Adam (1737_CR47) 2005; 106
US Arvindam (1737_CR230) 2021; 35
B Wang (1737_CR165) 2014; 74
DF Quail (1737_CR2) 2013; 19
V Brinkmann (1737_CR103) 2004; 303
A Jewett (1737_CR166) 2018; 53
D Bayik (1737_CR155) 2021; 21
H Yin (1737_CR209) 2022; 14
MH Mannino (1737_CR117) 2015; 367
B Nieswandt (1737_CR215) 1999; 59
1737_CR13
NC Bosch (1737_CR69) 2021; 22
1737_CR10
M Piper (1737_CR66) 2022; 28
K Rezvani (1737_CR19) 2017; 25
J Oberlies (1737_CR100) 2009; 182
JR Schafer (1737_CR177) 2019; 143
HB Jie (1737_CR64) 2015; 75
JD Rabinowitz (1737_CR184) 2020; 2
R Sun (1737_CR94) 2020; 13
S Regis (1737_CR114) 2017; 8
L Ireland (1737_CR134) 2020; 11
A Brand (1737_CR185) 2016; 24
L Bejarano (1737_CR3) 2021; 11
GY Lian (1737_CR131) 2022; 288
F Allen (1737_CR72) 2018; 7
S Wingert (1737_CR233) 2021; 13
JS Palumbo (1737_CR216) 2005; 105
A Crinier (1737_CR12) 2020; 180
X Lian (1737_CR180) 2022; 21
A Juillerat (1737_CR224) 2017; 7
MJ Smyth (1737_CR60) 2006; 176
A Teijeira (1737_CR106) 2020; 52
S Flommersfeld (1737_CR77) 2021; 54
F Ghiringhelli (1737_CR58) 2005; 202
F Otegbeye (1737_CR133) 2018; 13
C Costantini (1737_CR88) 2011; 117
W-N Li (1737_CR4) 2022; 14
MT Palano (1737_CR101) 2021; 9
GM Spaggiari (1737_CR149) 2006; 107
D Sarhan (1737_CR61) 2018; 6
JE Boudreau (1737_CR18) 2018; 39
P Neviani (1737_CR35) 2019; 79
A Tittarelli (1737_CR23) 2015; 290
DA Vallera (1737_CR236) 2016; 22
CJ Comerci (1737_CR26) 2012; 7
R Trotta (1737_CR129) 2008; 181
S Eisinger (1737_CR122) 2020; 117
A Shokouhifar (1737_CR156) 2021; 21
R Zhang (1737_CR128) 2019; 10
1737_CR105
1737_CR225
A Malhotra (1737_CR49) 2011; 3
RH Earls (1737_CR195) 2020; 117
KJ Murphy (1737_CR259) 2021; 72
S Zhong (1737_CR248) 2020; 13
A Sebestyén (1737_CR173) 2021; 27
LC Sullivan (1737_CR16) 2016; 291
HF Dvorak (1737_CR86) 1986; 315
A Chauveau (1737_CR24) 2010; 107
SY Wu (1737_CR6) 2020; 19
M Al-Hajj (1737_CR162) 2003; 100
RV Uzhachenko (1737_CR78) 1906; 2019
AE Overacre-Delgoffe (1737_CR206) 2021; 54
JJ Hodgins (1737_CR229) 2019; 129
C Gur (1737_CR210) 2015; 42
A Valayer (1737_CR95) 2017; 101
M Balsamo (1737_CR171) 2013; 43
L Chan (1737_CR102) 2022; 12
K Kaban (1737_CR37) 2021; 13
G Cai (1737_CR119) 1999; 29
MK Gleason (1737_CR232) 2014; 123
Y Liu (1737_CR212) 2016; 30
M Ardolino (1737_CR45) 2011; 117
1737_CR120
G Santoni (1737_CR199) 2021; 12
Y Li (1737_CR142) 2009; 17
M Giuliani (1737_CR151) 2014; 32
J Wang (1737_CR8) 2020; 43
S Ben-Eliyahu (1737_CR192) 1999; 80
A Desai (1737_CR153) 2019; 8
A Spiegel (1737_CR98) 2016; 6
S Carnevale (1737_CR87) 2020; 48
References_xml – volume: 117
  start-page: 32005
  year: 2020
  ident: 1737_CR122
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2015343117
– volume: 202
  start-page: 1075
  year: 2005
  ident: 1737_CR58
  publication-title: J Exp Med
  doi: 10.1084/jem.20051511
– volume: 192
  start-page: 1313
  year: 2014
  ident: 1737_CR21
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1301297
– volume: 13
  start-page: 473
  year: 2021
  ident: 1737_CR28
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13030473
– volume: 92
  start-page: 4248
  year: 1998
  ident: 1737_CR14
  publication-title: Blood
  doi: 10.1182/blood.V92.11.4248
– volume: 184
  start-page: 5338
  year: 2021
  ident: 1737_CR207
  publication-title: Cell
  doi: 10.1016/j.cell.2021.09.019
– ident: 1737_CR80
  doi: 10.1136/jitc-2020-001054
– ident: 1737_CR196
  doi: 10.1096/fj.08-105866
– volume: 22
  start-page: 10227
  year: 2021
  ident: 1737_CR69
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms221910227
– volume: 9
  start-page: 19
  year: 2016
  ident: 1737_CR130
  publication-title: Sci Signal
  doi: 10.1126/scisignal.aad1884
– volume: 9
  start-page: 1488
  year: 2021
  ident: 1737_CR101
  publication-title: Vaccines (Basel)
  doi: 10.3390/vaccines9121488
– volume: 42
  start-page: 344
  year: 2015
  ident: 1737_CR210
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.01.010
– volume: 23
  start-page: 369
  year: 2022
  ident: 1737_CR27
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-022-00460-3
– volume: 13
  start-page: e0191358
  year: 2018
  ident: 1737_CR133
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0191358
– volume: 315
  start-page: 1650
  year: 1986
  ident: 1737_CR86
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198612253152606
– volume: 24
  start-page: 1232
  year: 2022
  ident: 1737_CR84
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2022.07.012
– volume: 79
  start-page: 1151
  year: 2019
  ident: 1737_CR35
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-0779
– volume: 32
  start-page: 265
  year: 2011
  ident: 1737_CR118
  publication-title: Mol Cells
  doi: 10.1007/s10059-011-1057-8
– volume: 40
  start-page: 1022
  year: 2019
  ident: 1737_CR260
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2019.09.002
– volume: 488
  start-page: 196
  year: 2017
  ident: 1737_CR59
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.05.034
– volume: 184
  start-page: 6043
  year: 2010
  ident: 1737_CR43
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1000106
– volume: 318
  start-page: 154
  year: 2012
  ident: 1737_CR126
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2011.12.020
– volume: 35
  start-page: 109210
  year: 2021
  ident: 1737_CR179
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2021.109210
– volume: 8
  start-page: 1597
  year: 2017
  ident: 1737_CR175
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01599-w
– volume: 172
  start-page: e1014
  issue: 1022–1037
  year: 2018
  ident: 1737_CR71
  publication-title: Cell
– volume: 100
  start-page: 4120
  year: 2003
  ident: 1737_CR113
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0730640100
– volume: 10
  start-page: 1414
  year: 2019
  ident: 1737_CR176
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01414
– volume: 75
  start-page: 2200
  year: 2015
  ident: 1737_CR64
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-2788
– volume: 117
  start-page: 1677
  year: 2011
  ident: 1737_CR88
  publication-title: Blood
  doi: 10.1182/blood-2010-06-287243
– volume: 20
  start-page: 438
  year: 2012
  ident: 1737_CR145
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
– volume: 106
  start-page: 200
  year: 2014
  ident: 1737_CR11
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dju200
– volume: 8
  start-page: 75
  year: 2019
  ident: 1737_CR153
  publication-title: Stem Cells Transl Med
  doi: 10.1002/sctm.18-0123
– volume: 14
  start-page: 399
  year: 2017
  ident: 1737_CR108
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2016.217
– volume: 190
  start-page: 2381
  year: 2013
  ident: 1737_CR158
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201542
– volume: 12
  start-page: 643310
  year: 2021
  ident: 1737_CR55
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.643310
– volume: 6
  start-page: eaba8564
  year: 2020
  ident: 1737_CR246
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aba8564
– volume: 13
  start-page: 2397
  year: 2021
  ident: 1737_CR37
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13102397
– volume: 195
  start-page: 4010
  year: 2015
  ident: 1737_CR160
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1500447
– volume: 7
  start-page: e47664
  year: 2012
  ident: 1737_CR26
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0047664
– volume: 29
  start-page: 2658
  year: 1999
  ident: 1737_CR119
  publication-title: Eur J Immunol
  doi: 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G
– volume: 20
  start-page: 131
  year: 2021
  ident: 1737_CR124
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01428-1
– volume: 143
  start-page: 346
  year: 2019
  ident: 1737_CR177
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.06.047
– volume: 65
  start-page: 126
  year: 2014
  ident: 1737_CR97
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2013.11.010
– volume: 3
  start-page: e952197
  year: 2014
  ident: 1737_CR50
  publication-title: Oncoimmunology
  doi: 10.4161/21624011.2014.952197
– volume: 528
  start-page: 413
  year: 2015
  ident: 1737_CR89
  publication-title: Nature
  doi: 10.1038/nature16140
– volume: 12
  start-page: 66
  year: 2015
  ident: 1737_CR62
  publication-title: Retrovirology
  doi: 10.1186/s12977-015-0191-3
– volume: 57
  start-page: 213
  year: 2020
  ident: 1737_CR170
  publication-title: Semin Hematol
  doi: 10.1053/j.seminhematol.2020.10.003
– volume: 13
  start-page: 57
  year: 2020
  ident: 1737_CR248
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2019.10.001
– volume: 20
  start-page: 1656
  year: 2019
  ident: 1737_CR172
  publication-title: Nat Immunol
  doi: 10.1038/s41590-019-0511-1
– volume: 19
  start-page: 1858
  year: 2013
  ident: 1737_CR52
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-2426
– volume: 54
  start-page: 1320
  year: 2021
  ident: 1737_CR250
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.03.024
– volume: 52
  start-page: e858
  issue: 856–871
  year: 2020
  ident: 1737_CR106
  publication-title: Immunity
– volume: 111
  start-page: 2708
  year: 2020
  ident: 1737_CR125
  publication-title: Cancer Sci
  doi: 10.1111/cas.14537
– volume: 5
  start-page: 405
  year: 1999
  ident: 1737_CR68
  publication-title: Nat Med
  doi: 10.1038/7403
– volume: 72
  start-page: 41
  year: 2021
  ident: 1737_CR259
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2021.04.007
– volume: 290
  start-page: 23670
  year: 2015
  ident: 1737_CR23
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M115.651547
– volume: 9
  start-page: e003237
  year: 2021
  ident: 1737_CR226
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2021-003237
– volume: 49
  start-page: 1297
  year: 2016
  ident: 1737_CR127
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2016.3631
– volume: 77
  start-page: 467
  year: 2022
  ident: 1737_CR83
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2022.03.011
– volume: 117
  start-page: 1762
  year: 2020
  ident: 1737_CR195
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1909110117
– ident: 1737_CR154
  doi: 10.3390/ijms22084091
– volume: 287
  start-page: 15874
  year: 2012
  ident: 1737_CR30
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.340588
– volume: 11
  start-page: 933
  year: 2021
  ident: 1737_CR3
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-20-1808
– volume: 52
  start-page: 1075
  year: 2020
  ident: 1737_CR174
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.05.001
– volume: 132
  start-page: e157340
  year: 2022
  ident: 1737_CR208
  publication-title: J Clin Invest
  doi: 10.1172/JCI157340
– volume: 123
  start-page: 3016
  year: 2014
  ident: 1737_CR232
  publication-title: Blood
  doi: 10.1182/blood-2013-10-533398
– volume: 207
  start-page: 1907
  year: 2010
  ident: 1737_CR197
  publication-title: J Exp Med
  doi: 10.1084/jem.20092749
– volume: 11
  start-page: 621225
  year: 2020
  ident: 1737_CR112
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.621225
– volume: 32
  start-page: 290
  year: 2014
  ident: 1737_CR151
  publication-title: Stem Cells
  doi: 10.1002/stem.1563
– volume: 173
  start-page: 3716
  year: 2004
  ident: 1737_CR42
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.6.3716
– volume: 144
  start-page: 646
  year: 2011
  ident: 1737_CR167
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
– volume: 9
  start-page: 2358
  year: 2018
  ident: 1737_CR169
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02358
– volume: 14
  start-page: 1941
  year: 2022
  ident: 1737_CR209
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.203914
– volume: 101
  start-page: 253
  year: 2017
  ident: 1737_CR95
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.3AB0316-140RR
– ident: 1737_CR13
  doi: 10.4049/jimmunol.178.8.4947
– volume: 11
  start-page: 297
  year: 2020
  ident: 1737_CR134
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.00297
– volume: 43
  start-page: 577
  year: 2020
  ident: 1737_CR8
  publication-title: Cell Oncol (Dordr)
  doi: 10.1007/s13402-020-00523-7
– volume: 10
  start-page: 808859
  year: 2022
  ident: 1737_CR188
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2022.808859
– volume: 17
  start-page: 1301
  year: 2009
  ident: 1737_CR142
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
– volume: 74
  start-page: 665
  year: 2014
  ident: 1737_CR168
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-0992
– volume: 2014
  start-page: 143463
  year: 2014
  ident: 1737_CR144
  publication-title: Mediators Inflamm
  doi: 10.1155/2014/143463
– volume: 190
  start-page: 5355
  year: 2013
  ident: 1737_CR198
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1203401
– volume: 22
  start-page: 235
  year: 2021
  ident: 1737_CR253
  publication-title: Nat Rev Genet
  doi: 10.1038/s41576-020-00300-0
– volume: 163
  start-page: 5211
  year: 1999
  ident: 1737_CR56
  publication-title: J Immunol
  doi: 10.4049/jimmunol.163.10.5211
– volume: 10
  start-page: 228
  year: 2022
  ident: 1737_CR223
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-20-1023
– volume: 184
  start-page: 3163
  year: 2021
  ident: 1737_CR90
  publication-title: Cell
  doi: 10.1016/j.cell.2021.04.016
– volume: 23
  start-page: 420
  year: 2021
  ident: 1737_CR178
  publication-title: Mol Ther Oncolytics
  doi: 10.1016/j.omto.2021.06.005
– volume: 33
  start-page: 5584
  year: 2012
  ident: 1737_CR245
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2012.04.041
– volume: 382
  start-page: 545
  year: 2020
  ident: 1737_CR7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1910607
– volume: 182
  start-page: 5259
  year: 2009
  ident: 1737_CR100
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0803523
– volume: 21
  start-page: 526
  year: 2021
  ident: 1737_CR155
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-021-00366-w
– volume: 12
  start-page: 688918
  year: 2021
  ident: 1737_CR199
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.688918
– volume: 129
  start-page: 3499
  year: 2019
  ident: 1737_CR229
  publication-title: J Clin Invest
  doi: 10.1172/JCI129338
– volume: 8
  start-page: 868
  year: 2017
  ident: 1737_CR114
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00868
– volume: 44
  start-page: 924
  year: 2016
  ident: 1737_CR74
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.03.012
– volume: 7
  start-page: e2062
  year: 2016
  ident: 1737_CR137
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2015.327
– volume: 24
  start-page: 74
  year: 2006
  ident: 1737_CR140
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2004-0359
– volume: 20
  start-page: 966
  year: 2018
  ident: 1737_CR219
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-018-0138-8
– volume: 180
  start-page: e1281
  issue: 1280–1280
  year: 2020
  ident: 1737_CR12
  publication-title: Cell
– volume: 217
  start-page: e20190354
  year: 2020
  ident: 1737_CR104
  publication-title: J Exp Med
  doi: 10.1084/jem.20190354
– volume: 219
  start-page: e202001134
  year: 2020
  ident: 1737_CR213
  publication-title: J Cell Biol
  doi: 10.1083/jcb.202001134
– volume: 80
  start-page: 880
  year: 1999
  ident: 1737_CR192
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19990315)80:6<880::AID-IJC14>3.0.CO;2-Y
– volume: 12
  start-page: 121
  year: 2022
  ident: 1737_CR102
  publication-title: Cells
  doi: 10.3390/cells12010121
– volume: 28
  start-page: 194
  year: 2022
  ident: 1737_CR194
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2021.12.008
– volume: 37
  start-page: 1361
  year: 2010
  ident: 1737_CR22
  publication-title: Int J Oncol
– volume: 6
  start-page: 218
  year: 2021
  ident: 1737_CR123
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00641-0
– volume: 61
  start-page: 1255
  year: 2012
  ident: 1737_CR161
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-012-1200-1
– volume: 179
  start-page: 6651
  year: 2007
  ident: 1737_CR51
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.10.6651
– volume: 11
  start-page: 971
  year: 2021
  ident: 1737_CR211
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-21-0010
– volume: 59
  start-page: 1295
  year: 1999
  ident: 1737_CR215
  publication-title: Cancer Res
– volume: 6
  start-page: 860
  year: 2018
  ident: 1737_CR31
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-17-0604
– volume: 60
  start-page: 225
  year: 2020
  ident: 1737_CR136
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2019.06.003
– volume: 288
  start-page: 121730
  year: 2022
  ident: 1737_CR131
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2022.121730
– volume: 25
  start-page: 577
  year: 2021
  ident: 1737_CR228
  publication-title: Mol Diagn Ther
  doi: 10.1007/s40291-021-00550-6
– volume: 191
  start-page: 1486
  year: 2013
  ident: 1737_CR187
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1202702
– ident: 1737_CR53
  doi: 10.1038/s41586-022-04772-4
– volume: 6
  start-page: 1294368
  year: 2017
  ident: 1737_CR32
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2017.1294368
– volume: 184
  start-page: 810
  year: 2021
  ident: 1737_CR252
  publication-title: Cell
  doi: 10.1016/j.cell.2020.12.016
– volume: 18
  start-page: 997
  year: 2021
  ident: 1737_CR258
  publication-title: Nat Methods
  doi: 10.1038/s41592-021-01203-6
– volume: 112
  start-page: 258
  year: 2004
  ident: 1737_CR57
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2004.04.003
– volume: 182
  start-page: 1125
  year: 2020
  ident: 1737_CR25
  publication-title: Cell
  doi: 10.1016/j.cell.2020.07.019
– volume: 11
  start-page: 895
  year: 2012
  ident: 1737_CR242
  publication-title: Nat Mater
  doi: 10.1038/nmat3355
– volume: 9
  start-page: 473
  year: 2021
  ident: 1737_CR36
  publication-title: Ann Transl Med
  doi: 10.21037/atm-21-347
– volume: 22
  start-page: 827
  year: 2010
  ident: 1737_CR99
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxq434
– volume: 5
  start-page: 166
  year: 2020
  ident: 1737_CR5
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-020-00280-x
– ident: 1737_CR38
  doi: 10.3390/cancers11101560
– volume: 8
  start-page: 248
  year: 2017
  ident: 1737_CR182
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00248
– volume: 13
  start-page: 2184
  year: 2021
  ident: 1737_CR76
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13092184
– volume: 108
  start-page: 102417
  year: 2020
  ident: 1737_CR63
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2020.102417
– volume: 11
  start-page: 167
  year: 2020
  ident: 1737_CR238
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.00167
– volume: 22
  start-page: 3440
  year: 2016
  ident: 1737_CR236
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-15-2710
– volume: 14
  start-page: 11067
  year: 2020
  ident: 1737_CR132
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b10103
– volume: 112
  start-page: 1776
  year: 2008
  ident: 1737_CR41
  publication-title: Blood
  doi: 10.1182/blood-2008-02-135871
– volume: 67
  start-page: 1425
  year: 2018
  ident: 1737_CR70
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-018-2204-2
– volume: 13
  start-page: 97
  year: 2022
  ident: 1737_CR146
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-022-02777-4
– volume: 24
  start-page: 657
  year: 2016
  ident: 1737_CR185
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2016.08.011
– volume: 291
  start-page: 18740
  year: 2016
  ident: 1737_CR16
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M116.737130
– volume: 19
  start-page: 3844
  year: 2013
  ident: 1737_CR231
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-0505
– volume: 300
  start-page: 41
  year: 2016
  ident: 1737_CR159
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2015.11.009
– volume: 176
  start-page: 1582
  year: 2006
  ident: 1737_CR60
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.3.1582
– volume: 111
  start-page: 1869
  year: 2020
  ident: 1737_CR249
  publication-title: Cancer Sci
  doi: 10.1111/cas.14418
– volume: 2
  start-page: 566
  year: 2020
  ident: 1737_CR184
  publication-title: Nat Metab
  doi: 10.1038/s42255-020-0243-4
– volume: 10
  start-page: e005769
  year: 2022
  ident: 1737_CR48
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2022-005769
– volume: 31
  start-page: 227
  year: 2013
  ident: 1737_CR15
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075005
– volume: 106
  start-page: 338
  year: 2005
  ident: 1737_CR47
  publication-title: Blood
  doi: 10.1182/blood-2004-09-3775
– volume: 54
  start-page: e2287
  issue: 2288–2304
  year: 2021
  ident: 1737_CR77
  publication-title: Immunity
– volume: 13
  start-page: 2851
  year: 2015
  ident: 1737_CR79
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2015.11.053
– volume: 36
  start-page: 1006
  year: 2022
  ident: 1737_CR234
  publication-title: Leukemia
  doi: 10.1038/s41375-021-01478-w
– volume: 39
  start-page: 222
  year: 2018
  ident: 1737_CR18
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2017.12.001
– volume: 20
  start-page: 7
  year: 2020
  ident: 1737_CR67
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0210-z
– volume: 119
  start-page: e2200568119
  year: 2022
  ident: 1737_CR54
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2200568119
– volume: 101
  start-page: 108374
  year: 2021
  ident: 1737_CR111
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.108374
– volume: 19
  start-page: 120
  year: 2020
  ident: 1737_CR6
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01238-x
– volume: 2019
  start-page: 10
  year: 1906
  ident: 1737_CR78
  publication-title: Front Immunol
– ident: 1737_CR189
  doi: 10.1016/j.cell.2020.03.034
– volume: 175
  start-page: 1972
  year: 2018
  ident: 1737_CR256
  publication-title: Cell
  doi: 10.1016/j.cell.2018.11.021
– ident: 1737_CR105
  doi: 10.1172/JCI67484
– volume: 19
  start-page: 1423
  year: 2013
  ident: 1737_CR2
  publication-title: Nat Med
  doi: 10.1038/nm.3394
– volume: 17
  start-page: 598
  year: 2011
  ident: 1737_CR81
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2010.10.019
– volume: 7
  start-page: 2732
  year: 2017
  ident: 1737_CR33
  publication-title: Theranostics
  doi: 10.7150/thno.18752
– volume: 42
  start-page: 374
  year: 2022
  ident: 1737_CR200
  publication-title: Cancer Commun (Lond)
  doi: 10.1002/cac2.12294
– ident: 1737_CR186
  doi: 10.1158/2326-6066.CIR-18-0481
– volume: 6
  start-page: 163
  year: 2018
  ident: 1737_CR243
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-17-0273
– volume: 6
  start-page: 766
  year: 2018
  ident: 1737_CR61
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-17-0498
– volume: 200
  start-page: 1008
  year: 2018
  ident: 1737_CR115
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700737
– volume: 25
  start-page: 1769
  year: 2017
  ident: 1737_CR19
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2017.06.012
– volume: 134
  start-page: jcs258570
  year: 2021
  ident: 1737_CR201
  publication-title: J Cell Sci
  doi: 10.1242/jcs.258570
– volume: 165
  start-page: 45
  year: 2016
  ident: 1737_CR218
  publication-title: Cell
  doi: 10.1016/j.cell.2016.02.025
– volume: 24
  start-page: 1036
  year: 2018
  ident: 1737_CR20
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2018.10.005
– volume: 132
  start-page: 91
  year: 2006
  ident: 1737_CR96
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2005.05842.x
– volume: 367
  start-page: 103
  year: 2015
  ident: 1737_CR117
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.07.009
– volume: 9
  start-page: e003894
  year: 2021
  ident: 1737_CR222
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2021-003894
– volume: 95
  start-page: 357
  year: 2019
  ident: 1737_CR257
  publication-title: Acta Biomater
  doi: 10.1016/j.actbio.2019.02.014
– volume: 10
  start-page: 273
  year: 2019
  ident: 1737_CR128
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-1435-2
– volume: 5
  year: 2010
  ident: 1737_CR152
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0009874
– volume: 17
  start-page: 887
  year: 2018
  ident: 1737_CR107
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2018.169
– volume: 13
  start-page: 1
  year: 2006
  ident: 1737_CR85
  publication-title: Contrib Microbiol
– volume: 25
  start-page: 6614
  year: 2019
  ident: 1737_CR65
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-19-1090
– volume: 52
  start-page: 329
  year: 2013
  ident: 1737_CR183
  publication-title: Mol Carcinog
  doi: 10.1002/mc.21863
– volume: 175
  start-page: 1731
  year: 2018
  ident: 1737_CR239
  publication-title: Cell
  doi: 10.1016/j.cell.2018.10.014
– volume: 37
  start-page: 2089
  year: 2018
  ident: 1737_CR163
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0106-y
– volume: 18
  start-page: 85
  year: 2021
  ident: 1737_CR40
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-0426-7
– volume: 221
  start-page: 107753
  year: 2021
  ident: 1737_CR1
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2020.107753
– volume: 17
  start-page: 20
  year: 2021
  ident: 1737_CR164
  publication-title: Regen Ther
  doi: 10.1016/j.reth.2021.02.006
– volume: 182
  start-page: 3530
  year: 2009
  ident: 1737_CR157
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0802845
– volume: 21
  start-page: 15
  year: 2022
  ident: 1737_CR29
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01492-7
– volume: 105
  start-page: 178
  year: 2005
  ident: 1737_CR216
  publication-title: Blood
  doi: 10.1182/blood-2004-06-2272
– volume: 101
  start-page: 3052
  year: 2003
  ident: 1737_CR44
  publication-title: Blood
  doi: 10.1182/blood-2002-09-2876
– volume: 7
  start-page: 39833
  year: 2017
  ident: 1737_CR224
  publication-title: Sci Rep
  doi: 10.1038/srep39833
– volume: 30
  start-page: 668
  year: 2016
  ident: 1737_CR212
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.09.011
– volume: 37
  start-page: e96264
  year: 2018
  ident: 1737_CR202
  publication-title: Embo j
  doi: 10.15252/embj.201696264
– volume: 45
  start-page: 280
  year: 2016
  ident: 1737_CR17
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.07.005
– volume: 19
  start-page: 369
  year: 2019
  ident: 1737_CR109
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-019-0127-6
– volume: 7
  start-page: e1393598
  year: 2018
  ident: 1737_CR72
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2017.1393598
– ident: 1737_CR190
  doi: 10.1038/ncomms7623
– volume: 21
  start-page: 835
  year: 2020
  ident: 1737_CR237
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0728-z
– volume: 10
  start-page: 9
  year: 2019
  ident: 1737_CR82
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.00009
– volume: 27
  start-page: 1609802
  year: 2021
  ident: 1737_CR173
  publication-title: Pathol Oncol Res
  doi: 10.3389/pore.2021.1609802
– volume: 8
  start-page: eabj3286
  year: 2022
  ident: 1737_CR220
  publication-title: Sci Adv
  doi: 10.1126/sciadv.abj3286
– volume: 19
  start-page: 561
  year: 2003
  ident: 1737_CR46
  publication-title: Immunity
  doi: 10.1016/S1074-7613(03)00264-4
– volume: 118
  start-page: 3254
  year: 2011
  ident: 1737_CR143
  publication-title: Blood
  doi: 10.1182/blood-2010-12-325324
– volume: 100
  start-page: 3983
  year: 2003
  ident: 1737_CR162
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0530291100
– volume: 118
  start-page: e2101169118
  year: 2021
  ident: 1737_CR251
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2101169118
– ident: 1737_CR225
  doi: 10.1158/0008-5472.CAN-14-3041
– volume: 107
  start-page: 5545
  year: 2010
  ident: 1737_CR24
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0910074107
– volume: 236
  start-page: 2413
  year: 2021
  ident: 1737_CR138
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.30038
– ident: 1737_CR181
  doi: 10.1016/j.cell.2015.08.016
– ident: 1737_CR10
  doi: 10.3390/cancers13153865
– volume: 11
  start-page: 586126
  year: 2020
  ident: 1737_CR121
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.586126
– volume: 497
  start-page: 41
  year: 2021
  ident: 1737_CR214
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.09.021
– volume: 16
  start-page: 2791
  year: 2017
  ident: 1737_CR141
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2017.6921
– volume: 20
  start-page: 1547
  year: 2011
  ident: 1737_CR150
  publication-title: Cell Transplant
  doi: 10.3727/096368910X564076
– volume: 6
  start-page: 348
  year: 2018
  ident: 1737_CR92
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-17-0204
– volume: 18
  start-page: 1004
  year: 2017
  ident: 1737_CR116
  publication-title: Nat Immunol
  doi: 10.1038/ni.3800
– volume: 10
  start-page: e004725
  year: 2022
  ident: 1737_CR235
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2022-004725
– volume: 9
  start-page: 609532
  year: 2021
  ident: 1737_CR203
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2021.609532
– volume: 13
  start-page: 100825
  year: 2020
  ident: 1737_CR94
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2020.100825
– volume: 303
  start-page: 1532
  year: 2004
  ident: 1737_CR103
  publication-title: Science
  doi: 10.1126/science.1092385
– volume: 7
  start-page: 41
  year: 2016
  ident: 1737_CR205
  publication-title: For Immunopathol Dis Therap
– volume: 8
  start-page: 699
  year: 2017
  ident: 1737_CR9
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00699
– volume: 48
  start-page: 101409
  year: 2020
  ident: 1737_CR87
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2020.101409
– volume: 11
  start-page: 4387
  year: 2020
  ident: 1737_CR91
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-18125-0
– volume: 12
  start-page: 661
  year: 2020
  ident: 1737_CR34
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12030661
– volume: 21
  start-page: 27
  year: 2022
  ident: 1737_CR180
  publication-title: Mol Cancer
  doi: 10.1186/s12943-021-01486-5
– volume: 74
  start-page: 5746
  year: 2014
  ident: 1737_CR165
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-2563
– volume: 181
  start-page: 3784
  year: 2008
  ident: 1737_CR129
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.6.3784
– volume: 9
  start-page: e001341
  year: 2021
  ident: 1737_CR110
  publication-title: Cancer
– volume: 35
  start-page: 1586
  year: 2021
  ident: 1737_CR230
  publication-title: Leukemia
  doi: 10.1038/s41375-020-01065-5
– volume: 117
  start-page: 4778
  year: 2011
  ident: 1737_CR45
  publication-title: Blood
  doi: 10.1182/blood-2010-08-300954
– volume: 107
  start-page: 1484
  year: 2006
  ident: 1737_CR149
  publication-title: Blood
  doi: 10.1182/blood-2005-07-2775
– volume: 28
  start-page: 933
  year: 2019
  ident: 1737_CR148
  publication-title: Stem Cells and Dev
  doi: 10.1089/scd.2019.0059
– volume: 124
  start-page: 710
  year: 2014
  ident: 1737_CR93
  publication-title: Blood
  doi: 10.1182/blood-2014-03-453217
– volume: 5
  start-page: e10088
  year: 2010
  ident: 1737_CR147
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0010088
– volume: 3
  start-page: 1143
  year: 2011
  ident: 1737_CR49
  publication-title: Immunotherapy
  doi: 10.2217/imt.11.102
– volume: 13
  start-page: 816761
  year: 2022
  ident: 1737_CR227
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.816761
– volume: 40
  start-page: 327
  year: 2021
  ident: 1737_CR204
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-02128-w
– volume: 43
  start-page: 2756
  year: 2013
  ident: 1737_CR171
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201343448
– volume: 6
  start-page: 630
  year: 2016
  ident: 1737_CR98
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-15-1157
– volume: 12
  start-page: 695859
  year: 2021
  ident: 1737_CR191
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.695859
– volume: 12
  start-page: 733317
  year: 2021
  ident: 1737_CR254
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.733317
– volume: 9
  start-page: 1150
  year: 2018
  ident: 1737_CR135
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01150
– volume: 130
  start-page: 2560
  year: 2020
  ident: 1737_CR240
  publication-title: J Clin Invest
  doi: 10.1172/JCI132712
– volume: 14
  start-page: 2608
  year: 2022
  ident: 1737_CR4
  publication-title: Cancers
  doi: 10.3390/cancers14112608
– volume: 24
  start-page: 1178
  year: 2018
  ident: 1737_CR75
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0085-8
– volume: 53
  start-page: 178
  year: 2018
  ident: 1737_CR166
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2018.08.001
– volume: 12
  start-page: 3871
  year: 2020
  ident: 1737_CR241
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12123871
– volume: 21
  start-page: 682
  year: 2021
  ident: 1737_CR156
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-02400-1
– volume: 14
  start-page: e14073
  year: 2022
  ident: 1737_CR247
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.202114073
– volume: 13
  start-page: 1950264
  year: 2021
  ident: 1737_CR233
  publication-title: MAbs
  doi: 10.1080/19420862.2021.1950264
– volume: 111
  start-page: E5688
  year: 2014
  ident: 1737_CR73
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1411072112
– volume: 1
  start-page: 709
  year: 2020
  ident: 1737_CR217
  publication-title: Nat Cancer
  doi: 10.1038/s43018-020-0068-9
– volume: 54
  start-page: 2812
  year: 2021
  ident: 1737_CR206
  publication-title: Immunity
  doi: 10.1016/j.immuni.2021.11.003
– volume: 594
  start-page: 566
  year: 2021
  ident: 1737_CR221
  publication-title: Nature
  doi: 10.1038/s41586-021-03614-z
– ident: 1737_CR120
  doi: 10.1084/jem.20112738
– volume: 5
  start-page: 617
  year: 2004
  ident: 1737_CR193
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(04)01597-9
– volume: 20
  start-page: 437
  year: 2020
  ident: 1737_CR39
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-020-0272-z
– volume: 28
  start-page: 1013
  year: 2022
  ident: 1737_CR66
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-21-2767
– volume: 9
  start-page: 13819
  year: 2017
  ident: 1737_CR244
  publication-title: ACS Appl Mater Interfaces
  doi: 10.1021/acsami.7b02258
– volume: 18
  start-page: 106
  year: 2017
  ident: 1737_CR255
  publication-title: Lab Chip
  doi: 10.1039/C7LC00963A
– volume: 111
  start-page: 1327
  year: 2008
  ident: 1737_CR139
  publication-title: Blood
  doi: 10.1182/blood-2007-02-074997
SSID ssj0017874
Score 2.6153433
SecondaryResourceType review_article
Snippet Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of...
Abstract Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 34
SubjectTerms Adenosine
Antigens
Apoptosis
Cancer
Cancer therapies
Care and treatment
Cell interactions
Communication
Crosstalk
Cytokines
Cytotoxicity
Humans
Hypoxia
Immunotherapy
Killer cells
Killer Cells, Natural
Ligands
Metastases
Microenvironments
Natural killer cells
Neoplasms - metabolism
NK cells
Proteins
Review
Stem cells
TME
Tumor Microenvironment
Tumors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9RAFD5IQfFFtN5iq4wg-CChk5nMJX2rYilKC4KFvg1zWyy2aenuPvjvPWeSXRIEfTFPS2bCzJx8J-ebnXMBeOdb3UavVc15WNStDby2yNNrEYlec6mioNjh0zN9ct5-uVAXk1Jf5BM2pAceBHfQ-YZSwiDsMm9T9NYjiro26ShC4GJBX1-0eZvN1Hh-gDBsNyEyVh8s0aq1dF5JvkNGmtrMzFDJ1v_nN3lilOYOkxMLdPwYHo3UkR0NU34C93K_C_eHYpK_duHB6XhM_hS-nX1l9I_8kvm7zPqMcGX-6qbPh6xMBwn3T-b7xOI0PIRd9my1vsZh2DW56U1j4J7B-fHn759O6rF2Qh2Vlqs6Wr4QwQaPDC9F3OXhbxG8zilZKrbBm5ikVF3ulEczHZT2XuRgUpMDV8nL57DT47xeAqPD6c76rBZUBJznLmQfUiF2QuEwFTQbUbo4Jhan-hZXrmwwrHaD-B2K3xXxO1PBh-0zt0Najb_2_khvaNuTUmKXGwgUNwLF_QsoFbyn9-tIcXF60Y_xB7hISoHljnAo5Crc6Ar2Zz1R4eK8eYMQNyr80gmDl1Wl-e22mZ4kJ7Y-36xLH0vZb7Sq4MUAqO2SpDbIxK2owMygNlvzvKW__FHSgSPDlLKzr_6HkPbgoShaIupG78PO6m6dXyPrWoU3RcF-AzZCJqY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA86UfYic35VN4kg-CBhadqkqS-yDcdQNhAc3LeQrzuHW-92Px787z0nza23COtTaVJykpyPX5KTcwj5YGtVe6sk49xNWa0dZxpwOhMe4TWvpBd4d_jsXJ1e1N8mcpI33BbZrXKtE5OiDjOPe-QHooFHA3pRX27vGGaNwtPVnELjIXmEocuQq5vJsOAqgRnr9UUZrQ4WYNtqPLVED6KmalgzMkYpZv__mnnDNI3dJjfs0MkOeZoBJD3sZ_wZeRC7XfK4Tyn5Z5c8OcuH5c_Jj_PvFPflF9TOI-0iMC2117MufqaJHIDdv6ntAvWbl0ToVUeXqxtoht6gs97mTbgX5OLk68_jU5YzKDAvVbVkXvOpcNpZwHnBw1oP3oWzKoagMeUGL32oKtnGVlow1k4qa0V0TSij4zLY6iXZ6oCu14TiEXWrbZRTTAXOY-uidSHBOyGhmYKU66E0PocXxywX1yYtM7Qy_fAbGH6Tht80Bfk0_HPbB9e4t_YRztBQEwNjpw-z-aXJcmZaW2IEIdBSkdfBW21B6bR1UF44xwWQ-RHn16D4Anne5lsI0EkMhGUOoSlALMBmBdkb1QSx8-PiNYeYLPYL849JC_J-KMY_0ZWti7NVqqMxBo6SBXnVM9TQpUo1gMe1KEgzYrVRn8cl3dWvFBQccGZVtfrN_WS9Jdsi8b9gpdojW8v5Ku4Dqlq6d0l0_gKknh7Q
  priority: 102
  providerName: ProQuest
Title NK cells are never alone: crosstalk and communication in tumour microenvironments
URI https://www.ncbi.nlm.nih.gov/pubmed/36797782
https://www.proquest.com/docview/2777785076
https://www.proquest.com/docview/2778601665
https://pubmed.ncbi.nlm.nih.gov/PMC9933398
https://doaj.org/article/9a10131225e04dca8a51094d6c2bb02f
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rb9MwELf2EIgvCAaMjFEZCYkPKOA68SNICHVo01TUilelfrNsx4WJLmV9SOy_585NSiOm9Uur2onPl9_5zjnfHSEvbS5zb6VIGXOTNNeOpRrs9JR7NK9ZJjzH2OHBUJ6P8v5YjHdIU-6oZuDixq0d1pMazadv_lxdfwCBfx8FXsu3C9BZOXoj8WSQylSqdsk-aCaFFQ0G-T-vAoAzeplzJdNcFLoJornxHi1FFfP5_79qb6mt9pHKLR119oDcr41L2luj4SHZCdUBubMuN3l9QO4Oakf6I_Jl-IniO_sFtfNAqwCApnY6q8I7GskBbvyitiqp3w4goRcVXa4uYRh6iQf5tqPkHpPR2en3j-dpXV0h9UJmy9RrNuFOOws2YOlhHwi_ubMylKXGchys68ssE0UohAVF7oS0lgenym5wTJQ2e0L2KqDrKaHovi60DWKCZcJZKFywroymHxcwTEK6DSuNr1OPYwWMqYlbEC3Nmv0G2G8i-41KyOvNNb_XiTdu7X2CT2jTE5Nmxz9m8x-mlkFT2C5mF4IVLLC89FZbWJCKvJSeO8c4kPkKn69BsAF53tYRCjBJTJJlejAUWDNMyYQct3qCSPp2c4MQ0yDacAUfLWLzi00zXonH3KowW8U-GvPjSJGQwzWgNlPKpAJbXfOEqBbUWnNut1QXP2PCcLBBs6zQR7dT_Yzc4xH_PO3KY7K3nK_Cc7C4lq5DdtVYdch-r9f_1ofvk9Ph56-d-P6iE0XsL6hoKIM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEJcXBOMWGGAkEA8omuPEjoOE0LhMHV0rIW1S3zzbcWFiS0cvQvtT_EbOcS40Qtrb-lTVTn1sn8vn-FwIeWUymTkjRcyYncaZsixWgNNj7hBes1Q4jrHDo7EcHGVfJ2KyQf60sTDoVtnqxKCoy5nDd-Q7PIePAvQiP5z_irFqFN6utiU0arYY-ovfcGRbvN__DPv7mvO9L4efBnFTVSB2QqbL2Ck25VZZA9indHD-ge_cGunLUmEZCpa4Mk1F4QthwIBZIY3h3uZl4i0TpUnhf6-R62B4GR728kl3wEuA-bM2MEfJnQXY0gxvSdFjKU_zOO8Zv1Aj4H9LsGYK-26aa3Zv7y650wBWultz2D2y4astcqMuYXmxRW6Omsv5--TbeEjxHmBBzdzTyoOQUHM6q_w7GsgBmP-Tmqqkbj0ohZ5UdLk6g2HoGToHrkfePSBHV7K2D8lmBXQ9JhSvxAtlvJhi6XHmC-uNLQOc5AKGiUjSLqV2TTpzrKpxqsOxRkldL7-G5ddh-XUekbfdM-d1Mo9Le3_EHep6YiLu8MNs_l03cq0Lk2DGItCKnmWlM8qAkiuyUjpuLeNA5hvcX43qAshzpol6gEli4i29C0MBQgK2jsh2ryeIues3txyiGzWz0P-EIiIvu2Z8El3nKj9bhT4Kc-5IEZFHNUN1U0plDvhf8YjkPVbrzbnfUp38CEnIAdemaaGeXE7WC3JrcDg60Af74-FTcpsHWeBxIrfJ5nK-8s8A0S3t8yBGlBxftdz-BfDTXKk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NK+cells+are+never+alone%3A+crosstalk+and+communication+in+tumour+microenvironments&rft.jtitle=Molecular+cancer&rft.au=Zhou%2C+Yongqiang&rft.au=Cheng%2C+Lu&rft.au=Liu%2C+Lu&rft.au=Li%2C+Xun&rft.date=2023-02-16&rft.pub=BioMed+Central+Ltd&rft.issn=1476-4598&rft.eissn=1476-4598&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12943-023-01737-7&rft.externalDocID=A737614076
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon